🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This proof of concept study is designed to evaluate the efficacy and safety...
Status
Terminated
Location
Addenbrookes Hospital
Start Date
2008-03
Trial ID
NCT00542269
Treatments Being Tested
In addition to the blood pressure lowering effects of aliskiren, it may hav...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-05
Trial ID
NCT00923156
Treatments Being Tested
The study objective was to assess the effect of single and multiple doses o...
Status
Completed
Location
Novartis Investigator Site
Start Date
2008-04
Trial ID
NCT00660309
Treatments Being Tested
The goal of this project is to evaluate the chronic effect (8 weeks) of RAS...
Status
Completed
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2011-10
Trial ID
NCT01519635
Treatments Being Tested
Part 1 determined: aliskiren, amlodipine and angiotensin II concentrations ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2007-06
Trial ID
NCT00498433
Treatments Being Tested
This study compared the blunting effect of aliskiren and valsartan monother...
Status
Completed
Location
Investigative Site
Start Date
2009-02
Trial ID
NCT00819767
Treatments Being Tested
The study is designed to primarily assess the effect of aliskiren on albumi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01302899
This study will assess the effect of direct renin inhibition on nerve funct...
Status
Completed
Location
Christiana Care Health Services
Start Date
2009-06
Trial ID
NCT00935064
The study will evaluate the effects of the direct renin inhibitor, aliskire...
Status
Terminated
Location
UAB
Start Date
2011-06
Trial ID
NCT01349114
Treatments Being Tested
The investigators aim to assess if a new blood pressure medication, aliskir...
Status
Completed
Location
Texas Tech University Health Sciences Center
Start Date
2008-01
Trial ID
NCT00818779
Treatments Being Tested